UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of

The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 9, 2011

iTech Medical, Inc.

(Exact name of registrant as specified in its charter)


Delaware	000-52117	20-5153331
(State of other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

	17011 Beach Boulevard Suite 900 Huntington Beach, California 92647

	(Address of principal executive offices)

Registrant’s telephone number, including area code: (714) 841-2670

Not Applicable

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

ITEM 5.02 –Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On May 9, 2011, Craig Lunsman resigned as a member of the Board of Directors of the Company. Mr. Lunsman had no disagreement with the Company on any matter related to our operations, policies or practices.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	iTech Medical, Inc.

Date: May 11, 2011	By:	/s/ Warren G. Baker
		Chief Executive Officer

iTech Medical, Inc. 8-K